Direct presidential supervision in the health system
The president of Mexico, Claudia Sheinbaum Pardo, carried out an unannounced inspection visit to the Regional Hospital No. 2 of the Mexican Social Security Institute (IMSS) in Ciudad Juárez. The central objective of this action was to carry out an on-site evaluation of the drug supply and maintain a direct dialogue with the personnel responsible for the management of the hospital pharmacy. Through her social networks, the president documented the tour, showing interactions with the medical, nursing and administrative team of the institution. In a published message, Sheinbaum stated: “I was surprised to visit the Regional Hospital No. 2 of the IMSS in Ciudad Juárez to find out about the pharmacy’s supply; we spoke with those in charge. We are improving the delivery of medicines in all health institutions every day.” This statement underscores his administration’s focus on continuous improvement and empirical verification of conditions in medical units.
Comprehensive strategy to strengthen pharmaceutical supply
This supervision is part of a broader federal strategy designed to strengthen the public health system and guarantee timely access to medical treatments, one of the most persistent citizen demands. According to the analysis of presidential statements, these field interventions seek to identify operational bottlenecks and accelerate the resolution of historical delays in the supply chain. A fundamental pillar of this policy is the Wellness Pharmacies program, an initiative that aims to expand the network of access to free medicines, with special attention to communities with high demand and low coverage. The administration has categorized the optimization of the purchase, distribution and logistics of medical supplies as a transversal priority for all institutions in the sector, including IMSS, ISSSTE and IMSS-Bienestar, emphasizing the principles of transparency and centralized planning.
The sanctioning dimension of this strategy became evident on November 12, when the presidency reported that several pharmaceutical companies face administrative procedures that will disqualify them from the next procurement tender. This measure is a direct consequence of the breach of previously established delivery contracts. The sequence of events dates back to September, when the government issued a formal warning to 32 supplier companies that had not met their commitments, establishing a peremptory deadline until the end of that month. The non-compliance of this ultimatum by some firms motivated the intervention of the Secretary of Public Service (formerly the Anti-Corruption and Good Government Secretariat), which initiated the corresponding sanctioning processes. However, it should be noted that, as of the date of this analysis, after 74 days since the government announcement to make public the names of the offending companies, said information has not been officially disclosed, a point that raises questions about the full execution of the announced transparency policy.
The presidential visit to Ciudad Juárez, therefore, does not constitute an isolated act, but rather a tactical component within a public policy architecture designed to attack a multifaceted problem. It combines direct supervision, expansion of distribution infrastructure, and the imposition of contractual consequences on failed suppliers. The long-term effectiveness of this integrated approach will depend on consistency in its application, effective fluidity in the logistics chain and full accountability, including the promised publicity of non-compliance. Rigor in the implementation of each of these axes will be the key determinant to transform the declarations of intent into a reliable and permanent pharmaceutical supply for the user population.
Do you know someone who has benefited from Wellbeing Pharmacies or who has experience with the supply of medicines in public institutions? Share this note to expand the conversation about the transformation of the health system and explore more content related to public policies on our site.
